Page 1258 - Williams Hematology ( PDFDrive )

1232 Part IX: Lymphocytes and Plasma Cells Chapter 80: Immunodeficiency Diseases 1233

41. Glanzman ERP: Essentielle lymphocytophtise. Ein neues Krankheitsbild aus der 72. Muller SM, Ege M, Pottharst A, et al: Transplacentally acquired maternal T lymphocytes
Sauglingspathologie. Ann Paediatr 175, 1950. in severe combined immunodeficiency: A study of 121 patients. Blood 98:1847–1851,
42. Buckley RH: Molecular defects in human severe combined immunodeficiency and 2001.
approaches to immune reconstitution. Annu Rev Immunol 22:625–655, 2004. 73. Palmer K, Green TD, Roberts JL, et al: Unusual clinical and immunologic manifesta-
43. Fischer A, Le Deist F, Hacein-Bey-Abina S, et al: Severe combined immunodeficiency. tions of transplacentally acquired maternal T cells in severe combined immunodefi-
A model disease for molecular immunology and therapy. Immunol Rev 203:98–109, ciency. J Allergy Clin Immunol 120:423–428, 2007.
2005. 74. Shearer WT, Dunn E, Notarangelo LD, et al: Establishing diagnostic criteria for severe
44. Al-Herz W, Bousfiha A, Casanova JL, et al: Primary immunodeficiency diseases: An combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The
update on the classification from the international union of immunological societies Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol
expert committee for primary immunodeficiency. Front Immunol 5:162, 2014. 133:1092–1098, 2014.
45. Grunebaum E, Cohen A, Roifman CM: Recent advances in understanding and manag- 75. Hirschhorn R: In vivo reversion to normal of inherited mutations in humans. J Med
ing adenosine deaminase and purine nucleoside phosphorylase deficiencies. Curr Opin Genet 40:721–728, 2003.
Allergy Clin Immunol 13:630–638, 2013. 76. Kwan A, Abraham RS, Currier R, et al: Newborn screening for severe combined immu-
46. Cassani B, Mirolo M, Cattaneo F, et al: Altered intracellular and extracellular signaling nodeficiency in 11 screening programs in the United States. JAMA 312:729–738, 2014.
leads to impaired T-cell functions in ADA-SCID patients. Blood 111:4209–4219, 77. Engel BC, Podsakoff GM, Ireland JL, et al: Prolonged pancytopenia in a gene ther-
2008. apy patient with ADA-deficient SCID and trisomy 8 mosaicism: A case report. Blood
47. Cohen AGE, Arpaia E, Roifman CM: Immunodeficiency caused by purine nucleoside 109:503–506, 2007.
phosphorylase deficiency. Immunol Allergy Clin North Am 20 (1):143–159, 2000. 78. Dror Y, Grunebaum E, Hitzler J, et al: Purine nucleoside phosphorylase deficiency asso-
48. Small TN, Wall DA, Kurtzberg J, et al: Association of reticular dysgenesis (thymic alym- ciated with a dysplastic marrow morphology. Pediatr Res 55:472–477, 2004.
phoplasia and congenital aleukocytosis) with bilateral sensorineural deafness. J Pediatr 79. Buck D, Malivert L, de Chasseval R, et al: Cernunnos, a novel nonhomologous end-
135:387–389, 1999. joining factor, is mutated in human immunodeficiency with microcephaly. Cell
49. Pannicke U, Honig M, Hess I, et al: Reticular dysgenesis (aleukocytosis) is caused by 124:287–299, 2006.
mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet 41:101– 80. Faraci M, Lanino E, Micalizzi C, et al: Unrelated hematopoietic stem cell transplanta-
105, 2009. tion for Cernunnos-XLF deficiency. Pediatr Transplant 13:785–789, 2009.
50. Lagresle-Peyrou C, Six EM, Picard C, et al: Human adenylate kinase 2 deficiency causes 81. Gruhn B, Seidel J, Zintl F, et al: Successful bone marrow transplantation in a patient
a profound hematopoietic defect associated with sensorineural deafness. Nat Genet with DNA ligase IV deficiency and bone marrow failure. Orphanet J Rare Dis 2:5, 2007.
41:106–111, 2009. 82. Cossu F, Vulliamy TJ, Marrone A, et al: A novel DKC1 mutation, severe combined
51. Rochman Y, Spolski R, Leonard WJ: New insights into the regulation of T cells by gam- immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant
ma(c) family cytokines. Nat Rev Immunol 9:480–490, 2009. with Hoyeraal-Hreidarsson syndrome. Br J Haematol 119:765–768, 2002.
52. Noguchi M, Yi H, Rosenblatt HM, et al: Interleukin-2 receptor gamma chain mutation 83. Hitzig WH, Kenny AB: The role of vitamin B12 and its transport globulins in the pro-
results in X-linked severe combined immunodeficiency in humans. Cell 73:147–157, duction of antibodies. Clin Exp Immunol 20:105–111, 1975.
1993. 84. Wong SN, Low LC, Lau YL, et al: Immunodeficiency in methylmalonic acidaemia.
53. Macchi P, Villa A, Giliani S, et al: Mutations of Jak-3 gene in patients with autosomal J Paediatr Child Health 28:180–183, 1992.
severe combined immune deficiency (SCID). Nature 377:65–68, 1995. 85. Gatti RA, Meuwissen HJ, Allen HD, et al: Immunological reconstitution of sex-linked
54. Russell SM, Tayebi N, Nakajima H, et al: Mutation of Jak3 in a patient with SCID: lymphopenic immunological deficiency. Lancet 2:1366–1369, 1968.
Essential role of Jak3 in lymphoid development. Science 270:797–800, 1995. 86. Pai SY, Logan BR, Griffith LM, et al: Transplantation outcomes for severe combined
55. Puel A, Ziegler SF, Buckley RH, et al: Defective IL7R expression in T(-)B(+)NK(+) immunodeficiency, 2000–2009. N Engl J Med 371:434–446, 2014.
severe combined immunodeficiency. Nat Genet 20:394–397, 1998. 87. Honig M, Albert MH, Schulz A, et al: Patients with adenosine deaminase deficiency
56. Neven B, Leroy S, Decaluwe H, et al: Long-term outcome after hematopoietic stem cell surviving after hematopoietic stem cell transplantation are at high risk of CNS compli-
transplantation of a single-center cohort of 90 patients with severe combined immuno- cations. Blood 109:3595–3602, 2007.
deficiency. Blood 113:4114–4124, 2009. 88. Titman P, Pink E, Skucek E, et al: Cognitive and behavioral abnormalities in children
57. Moshous D, Callebaut I, de Chasseval R, et al: Artemis, a novel DNA double-strand after hematopoietic stem cell transplantation for severe congenital immunodeficien-
break repair/V(D)J recombination protein, is mutated in human severe combined cies. Blood 112:3907–3913, 2008.
immune deficiency. Cell 105:177–186, 2001. 89. Schuetz C, Neven B, Dvorak CC, et al: SCID patients with ARTEMIS vs RAG deficien-
58. van der Burg M, Ijspeert H, Verkaik NS, et al: A DNA-PKcs mutation in a radiosensitive cies following HCT: Increased risk of late toxicity in ARTEMIS-deficient SCID. Blood
T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin 123:281–289, 2014.
Invest 119:91–98, 2009. 90. Aiuti A, Cattaneo F, Galimberti S, et al: Gene therapy for immunodeficiency due to
59. Buck D, Moshous D, de Chasseval R, et al: Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med 360:447–458, 2009.
microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol 91. Gaspar HB, Cooray S, Gilmour KC, et al: Hematopoietic stem cell gene therapy for
36:224–235, 2006. adenosine deaminase-deficient severe combined immunodeficiency leads to long-term
60. van der Burg M, van Veelen LR, Verkaik NS, et al: A new type of radiosensitive immunological recovery and metabolic correction. Sci Transl Med 3:97ra80, 2011.
T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 92. Candotti F, Shaw KL, Muul L, et al: Gene therapy for adenosine deaminase-deficient
116:137–145, 2006. severe combined immune deficiency: Clinical comparison of retroviral vectors and
61. Ahnesorg P, Smith P, Jackson SP: XLF interacts with the XRCC4-DNA ligase IV com- treatment plans. Blood 120:3635–3646, 2012.
plex to promote DNA nonhomologous end-joining. Cell 124:301–313, 2006. 93. Hacein-Bey-Abina S, Hauer J, Lim A, et al: Efficacy of gene therapy for X-linked severe
62. Dadi HK, Simon AJ, Roifman CM: Effect of CD3delta deficiency on maturation of combined immunodeficiency. N Engl J Med 363:355–364, 2010.
alpha/beta and gamma/delta T-cell lineages in severe combined immunodeficiency. 94. Gaspar HB, Cooray S, Gilmour KC, et al: Long-term persistence of a polyclonal T cell
N Engl J Med 349:1821–1828, 2003. repertoire after gene therapy for X-linked severe combined immunodeficiency. Sci
63. de Saint Basile G, Geissmann F, Flori E, et al: Severe combined immunodeficiency Transl Med 3:97ra79, 2011.
caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest 95. Hacein-Bey-Abina S, Garrigue A, Wang GP, et al: Insertional oncogenesis in 4 patients
114:1512–1517, 2004. after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118:3132–3142, 2008.
64. Rieux-Laucat F, Hivroz C, Lim A, et al: Inherited and somatic CD3zeta mutations in a 96. Howe SJ, Mansour MR, Schwarzwaelder K, et al: Insertional mutagenesis combined
patient with T-cell deficiency. N Engl J Med 354:1913–1921, 2006. with acquired somatic mutations causes leukemogenesis following gene therapy of
65. Arnaiz-Villena A, Timon M, Corell A, et al: Brief report: Primary immunodeficiency SCID-X1 patients. J Clin Invest 118:3143–3150, 2008.
caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte 97. Hacein-Bey-Abina S, Pai SY, Gaspar HB: Improved gene therapy for X-linked severe
receptor. N Engl J Med 327:529–533, 1992. combined immunodeficiency. N Engl J Med 371:1407–1417, 2014.
66. Recio MJ, Moreno-Pelayo MA, Kilic SS, et al: Differential biological role of CD3 chains 98. Omenn GS: Familial reticuloendotheliosis with eosinophilia. N Engl J Med 273:427–
revealed by human immunodeficiencies. J Immunol 178:2556–2564, 2007. 432, 1965.
67. Morgan NV, Goddard S, Cardno TS, et al: Mutation in the TCRalpha subunit constant 99. Signorini S, Imberti L, Pirovano S, et al: Intrathymic restriction and peripheral expan-
gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of sion of the T-cell repertoire in Omenn syndrome. Blood 94:3468–3478, 1999.
TCRalphabeta+ T cells. J Clin Invest 121:695–702, 2011. 100. Villa A, Santagata S, Bozzi F, et al: Partial V(D)J recombination activity leads to Omenn
68. Kung C, Pingel JT, Heikinheimo M, et al: Mutations in the tyrosine phosphatase CD45 gene syndrome. Cell 93:885–896, 1998.
in a child with severe combined immunodeficiency disease. Nat Med 6:343–345, 2000. 101. Marrella V, Maina V, Villa A: Omenn syndrome does not live by V(D)J recombination
69. Tchilian EZ, Wallace DL, Wells RS, et al: A deletion in the gene encoding the CD45 alone. Curr Opin Allergy Clin Immunol 11:525–531, 2011.
antigen in a patient with SCID. J Immunol 166:1308–1313, 2001. 102. Cavadini P, Vermi W, Facchetti F, et al: AIRE deficiency in thymus of 2 patients with
70. Buckley RH, Schiff RI, Schiff SE, et al: Human severe combined immunodeficiency: Omenn syndrome. J Clin Invest 115:728–732, 2005.
Genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 103. Villa A, Marrella V, Rucci F, et al: Genetically determined lymphopenia and autoim-
130:378–387, 1997. mune manifestations. Curr Opin Immunol 20:318–324, 2008.
71. Yeganeh M, Heidarzade M, Pourpak Z, et al: Severe combined immunodeficiency: A 104. Villa A, Notarangelo LD, Roifman CM: Omenn syndrome: Inflammation in leaky
cohort of 40 patients. Pediatr Allergy Immunol 19:303–306, 2008. severe combined immunodeficiency. J Allergy Clin Immunol 122:1082–1086, 2008.

Kaushansky_chapter 80_p1211-1238.indd 1233 9/18/15 10:02 AM